UniProt ID | SNX1_MOUSE | |
---|---|---|
UniProt AC | Q9WV80 | |
Protein Name | Sorting nexin-1 | |
Gene Name | Snx1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 522 | |
Subcellular Localization |
Endosome membrane Peripheral membrane protein Cytoplasmic side. Golgi apparatus, trans-Golgi network membrane Peripheral membrane protein Cytoplasmic side . Early endosome membrane Peripheral membrane protein Cytoplasmic side. Cell projection, la |
|
Protein Description | Involved in several stages of intracellular trafficking. Interacts with membranes containing phosphatidylinositol 3-phosphate (PtdIns(3P)) or phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). Acts in part as component of the retromer membrane-deforming SNX-BAR subcomplex. The SNX-BAR retromer mediates retrograde transport of cargo proteins from endosomes to the trans-Golgi network (TGN) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. The SNX-BAR subcomplex functions to deform the donor membrane into a tubular profile called endosome-to-TGN transport carrier (ETC). Can sense membrane curvature and has in vitro vesicle-to-membrane remodeling activity. Involved in retrograde endosome-to-TGN transport of lysosomal enzyme receptors (IGF2R, M6PR and SORT1). Plays a role in targeting ligand-activated EGFR to the lysosomes for degradation after endocytosis from the cell surface and release from the Golgi. Involvement in retromer-independent endocytic trafficking of P2RY1 and lysosomal degradation of protease-activated receptor-1/F2R. Promotes KALRN- and RHOG-dependent but retromer-independent membrane remodeling such as lamellipodium formation; the function is dependent on GEF activity of KALRN. Required for endocytosis of DRD5 upon agonist stimulation but not for basal receptor trafficking (By similarity).. | |
Protein Sequence | MASGGGGCSASERLPPPFPGMDPESEGAAGASEPEAGDSDTEGEDIFTGAAAATKPQSPKKTTSLFPIKNGSKENGIHEDQDQEPQDLFADATVELSLDSTQNNQKTMPGKTLTSHSPQEATNSPKPQPSYEELEEEEQEDQFDLTVGITDPEKIGDGMNAYVAYKVTTQTSLPMFRSRQFAVKRRFSDFLGLYEKLSEKHSQNGFIVPPPPEKSLIGMTKVKVGKEDSSSAEFLEKRRAALERYLQRIVNHPTMLQDPDVREFLEKEELPRAVGTQALSGAGLLKMFNKATDAVSKMTIKMNESDIWFEEKLQEVECEEQRLRKLHAVVETLVNHRKELALNTALFAKSLAMLGSSEDNTALSRALSQLAEVEEKIEQLHQEQANNDSFLLAELLSDYIRLLAIVRAAFDQRMKTWQRWQDAQATLQKKRESEARLLWANKPDKLQQAKDEITEWESRVTQYERDFERISTVVRKEVTRFEKEKSKDFKNHVMKYLETLLHSQQQLAKYWEAFLPEAKAIS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
25 | Phosphorylation | FPGMDPESEGAAGAS CCCCCHHCCCCCCCC | 46.87 | 21082442 | |
32 | Phosphorylation | SEGAAGASEPEAGDS CCCCCCCCCCCCCCC | 53.41 | 21743459 | |
39 | Phosphorylation | SEPEAGDSDTEGEDI CCCCCCCCCCCCCCC | 45.58 | 21743459 | |
41 | Phosphorylation | PEAGDSDTEGEDIFT CCCCCCCCCCCCCCC | 50.25 | 21743459 | |
48 | Phosphorylation | TEGEDIFTGAAAATK CCCCCCCCCCHHCCC | 26.67 | 22817900 | |
54 | Phosphorylation | FTGAAAATKPQSPKK CCCCHHCCCCCCCCC | 38.23 | 22817900 | |
58 | Phosphorylation | AAATKPQSPKKTTSL HHCCCCCCCCCCCCC | 47.41 | 21743459 | |
72 | Phosphorylation | LFPIKNGSKENGIHE CEECCCCCCCCCCCC | 46.30 | 29514104 | |
117 | Phosphorylation | GKTLTSHSPQEATNS CCCCCCCCCCHHHCC | 28.22 | 28507225 | |
122 | Phosphorylation | SHSPQEATNSPKPQP CCCCCHHHCCCCCCC | 35.16 | 22807455 | |
124 | Phosphorylation | SPQEATNSPKPQPSY CCCHHHCCCCCCCCH | 29.91 | 22807455 | |
188 | Phosphorylation | FAVKRRFSDFLGLYE HHHHHHHHHHHHHHH | 26.16 | 26824392 | |
196 | Ubiquitination | DFLGLYEKLSEKHSQ HHHHHHHHHHHHHHC | 43.70 | - | |
229 | Phosphorylation | VKVGKEDSSSAEFLE EEECCCCCCHHHHHH | 27.55 | 19367708 | |
230 | Phosphorylation | KVGKEDSSSAEFLEK EECCCCCCHHHHHHH | 45.98 | 29176673 | |
231 | Phosphorylation | VGKEDSSSAEFLEKR ECCCCCCHHHHHHHH | 35.45 | 29176673 | |
237 | Acetylation | SSAEFLEKRRAALER CHHHHHHHHHHHHHH | 49.70 | 90447 | |
280 | Phosphorylation | AVGTQALSGAGLLKM HHHHHHHCHHHHHHH | 29.61 | 27180971 | |
286 | Ubiquitination | LSGAGLLKMFNKATD HCHHHHHHHHHHHHH | 46.63 | - | |
318 | S-palmitoylation | EKLQEVECEEQRLRK HHHHHCCCHHHHHHH | 9.36 | 28680068 | |
368 | Phosphorylation | TALSRALSQLAEVEE HHHHHHHHHHHHHHH | 23.35 | 26824392 | |
450 | Ubiquitination | PDKLQQAKDEITEWE CHHHHHHHHHHHHHH | 52.10 | - | |
463 | Phosphorylation | WESRVTQYERDFERI HHHHHHHHHHHHHHH | 11.99 | - | |
495 | Ubiquitination | DFKNHVMKYLETLLH HHHHHHHHHHHHHHH | 45.66 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SNX1_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SNX1_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SNX1_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of SNX1_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-188, AND MASSSPECTROMETRY. |